MX2010008688A - Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. - Google Patents

Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria.

Info

Publication number
MX2010008688A
MX2010008688A MX2010008688A MX2010008688A MX2010008688A MX 2010008688 A MX2010008688 A MX 2010008688A MX 2010008688 A MX2010008688 A MX 2010008688A MX 2010008688 A MX2010008688 A MX 2010008688A MX 2010008688 A MX2010008688 A MX 2010008688A
Authority
MX
Mexico
Prior art keywords
engineered anti
tslpr antibodies
tslpr
antibodies
engineered
Prior art date
Application number
MX2010008688A
Other languages
English (en)
Inventor
Leonard G Presta
Waal Malefyt Rene De
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2010008688A publication Critical patent/MX2010008688A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Abstract

La invención se refiere a compuestos de unión que específicamente se unen al TSLPR humano, así como también a usos de los mismos, por ejemplo, en el tratamiento de trastornos inflamatorios.
MX2010008688A 2008-02-07 2009-02-06 Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. MX2010008688A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2683308P 2008-02-07 2008-02-07
US4203008P 2008-04-03 2008-04-03
PCT/US2009/033383 WO2009100324A1 (en) 2008-02-07 2009-02-06 Engineered anti-tslpr antibodies

Publications (1)

Publication Number Publication Date
MX2010008688A true MX2010008688A (es) 2010-08-30

Family

ID=40622088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008688A MX2010008688A (es) 2008-02-07 2009-02-06 Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria.

Country Status (8)

Country Link
US (1) US8475793B2 (es)
EP (1) EP2250199B1 (es)
JP (2) JP2011511638A (es)
CN (1) CN101986784A (es)
AR (1) AR070346A1 (es)
CA (1) CA2713935C (es)
MX (1) MX2010008688A (es)
WO (1) WO2009100324A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008155365A1 (en) 2007-06-20 2008-12-24 Irm Llc Methods and compositions for treating allergic diseases
JOP20080381B1 (ar) 2007-08-23 2023-03-28 Amgen Inc بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
EP2320731A4 (en) 2008-05-27 2012-09-26 Intra Cellular Therapies Inc METHOD AND COMPOSITIONS FOR SLEEPING AND OTHER DISORDERS
AR082163A1 (es) 2010-07-15 2012-11-14 Hoffmann La Roche Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos
WO2012054438A1 (en) * 2010-10-22 2012-04-26 Schering Corporation Anti-pcsk9
ES2730978T3 (es) 2013-08-09 2019-11-13 Astellas Pharma Inc Anticuerpo anti-receptor de TSLP humana nuevo
US9790506B2 (en) 2013-10-02 2017-10-17 The Regents Of The University Of California Diagnostic and screening methods for atopic dermatitis
KR20230023817A (ko) 2013-12-03 2023-02-17 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
EP3077416B1 (en) 2013-12-06 2019-06-19 The United States of America, as represented by The Secretary, Department of Health and Human Services Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same
DK3347377T3 (da) 2015-09-09 2021-05-10 Novartis Ag Tymisk stromal lymfopoietin (TSLP)-bindende antistoffer og fremgangsmåder til anvendelse af antistofferne
TN2018000076A1 (en) 2015-09-09 2019-07-08 Novartis Ag Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules
KR20180088906A (ko) 2015-12-18 2018-08-07 아스텔라스세이야쿠 가부시키가이샤 항인간 tslp 수용체 항체 함유 의약 조성물
DK3407888T3 (da) 2016-01-26 2021-04-06 Intra Cellular Therapies Inc Pyridopyrroloquinoxalinforbindelser, deres sammensætninger og anvendelser
WO2017146011A1 (ja) * 2016-02-22 2017-08-31 国立大学法人 千葉大学 アレルギー性鼻炎の診断用バイオマーカー
US11014925B2 (en) 2016-03-28 2021-05-25 Intra-Cellular Therapies, Inc. Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
JP6987868B2 (ja) 2016-12-29 2022-01-05 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
RU2767410C2 (ru) 2017-03-24 2022-03-17 Интра-Селлулар Терапиз, Инк. Новые композиции и способы
KR20200106498A (ko) * 2018-01-05 2020-09-14 이뮤넥스트, 인크. 항-mct1 항체 및 그의 용도
EP3843739A4 (en) 2018-08-31 2022-06-01 Intra-Cellular Therapies, Inc. NEW METHODS
JP2021536453A (ja) 2018-08-31 2021-12-27 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規方法
AU2020217012A1 (en) * 2019-02-01 2021-08-19 Novarock Biotherapeutics, Ltd. Anti-claudin 18 antibodies and methods of use thereof
US20220298255A1 (en) * 2019-05-31 2022-09-22 Seattle Children's Hospital D/B/A Seattle Children's Research Institute E-cadherin activating antibodies and uses thereof
CN114887053A (zh) * 2019-11-29 2022-08-12 康诺亚生物医药科技（成都）有限公司 一种tslp相关病症治疗剂的开发和应用
CN113501878B (zh) * 2021-02-03 2022-12-02 北京智仁美博生物科技有限公司 针对人tslp的多种抗体及其用途
WO2023028612A2 (en) 2021-08-27 2023-03-02 Board Of Regents, The University Of Texas System Anti-tslpr (crlf2) antibodies
WO2023155132A1 (zh) * 2022-02-18 2023-08-24 绍兴守仁医疗健康科技有限公司 Rac1蛋白单克隆抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391124T3 (es) 2000-06-28 2012-11-21 Amgen Inc. Moléculas de receptor de linfopoyetina estromal tímica y usos de las mismas
CA2577631A1 (en) * 2004-08-20 2006-03-02 Amgen Inc. Methods and compositions for treating allergic inflammation
CN101370831B (zh) 2006-01-13 2013-06-19 Irm责任有限公司 用于治疗过敏性疾病的针对胸腺基质淋巴细胞生成素受体的抗体
WO2008155365A1 (en) * 2007-06-20 2008-12-24 Irm Llc Methods and compositions for treating allergic diseases

Also Published As

Publication number Publication date
EP2250199B1 (en) 2015-09-02
US8475793B2 (en) 2013-07-02
CA2713935C (en) 2016-11-01
EP2250199A1 (en) 2010-11-17
CN101986784A (zh) 2011-03-16
JP2013223516A (ja) 2013-10-31
AR070346A1 (es) 2010-03-31
WO2009100324A1 (en) 2009-08-13
US20110020369A1 (en) 2011-01-27
CA2713935A1 (en) 2009-08-13
JP2011511638A (ja) 2011-04-14

Similar Documents

Publication Publication Date Title
MX2010008688A (es) Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria.
MX2009006471A (es) Anticuerpo anti especifico de linfopoyetina estromal timica de diseño.
MY162511A (en) Engineered anti-tslp antibody
MX362039B (es) Anticuerpos anti-il-23.
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
TN2010000213A1 (en) Wise binding antibodies and epitopes
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
MX2009009079A (es) Anticuerpos anti-il-23p19 de ingenieria.
WO2012109373A3 (en) Treatment of osteoarthritis and pain
MX2009009080A (es) Anticuerpos anti-interleucina-23p19 manipulados por ingenieria genetica.
TW201129377A (en) Binding proteins that bind to human FGFR1c, human β-Klotho and both human FGFR1c and human β-Klotho
MX2012005037A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
MX2012004415A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
SG178602A1 (en) Dual variable domain immunoglobulins and uses thereof
MX2012001262A (es) Inmunoglobulinas de dominio variable doble y usos de las misma.
MX2011011669A (es) Inmunoglobulinas de dominio variable dual y usos de las misma.
EA201400579A1 (ru) Антитела к il-36r
MY163368A (en) Il-1-alpha and -beta bispecific dual variable domain immunoglobulins and their use
PH12017500864A1 (en) Anti-notch1 antibodies
NZ709353A (en) Antibodies that bind il-4 and/or il-13 and their uses
EP2373692A4 (en) IMMUNOGLOBULINE WITH DOUBLE VARIABLE DOMAIN AND ITS USE
MY161679A (en) Polypeptides
PH12013502205A1 (en) Antibodies to il-6 and their uses
MX2009009283A (es) Anticuerpos anti-interleuquina -23r de ingenieria.
MY165273A (en) Anti-cd48 antibodies and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status